aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2024. All rights reserved.
44 Tehama St, San Francisco, CA 94105
Privacy Policy
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
Medix Infusion is a technology-enabled healthcare platform dedicated to enhancing patient care by connecting chronically ill and high-acuity patients with infusion therapy. The company focuses on providing convenient, compassionate care within rural, suburban, and other underserved markets. Medix Infusion offers treatments at local clinics, ensuring accessibility and quality care for patients who need regular infusion therapies.
Medix Infusion has made significant strides in improving access to healthcare for underserved populations. By leveraging technology and a patient-centric approach, the company has positively impacted the lives of many individuals requiring infusion therapy. Their commitment to compassionate care and convenience has set them apart in the healthcare industry, making a substantial difference in patient outcomes and overall well-being.
Operating Status
Active
Main Product(s)
Healthcare, Infusion Therapy
Technology
Telemedicine
Tags
Healthtech
Model Types
Platform
Revenue Type(s)
Recurring
Customer Type(s)
Consumers
Geographic Exposure
United States
When was Medix Infusion founded?
Medix Infusion was founded in 2020.
Where is Medix Infusion’s headquarters located?
Medix Infusion’s headquarters is located in Addison, US.
How many employees does Medix Infusion have?
Medix Infusion has 119 employees as of Feb 5, 2024.
How much has Medix Infusion raised to-date?
As of July 05, 2023, Medix Infusion has raised a total of $35M (USD) since Jan 9, 2023.
Add Comparison
Total Raised to Date
$35M
USD
Last Update Jan 9, 2023
Total Employees Over Time
119
As of Feb 2024
Medix Infusion Address
15301 Spectrum Dr
Suite 330
Addison,
75001
United States
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts